137 related articles for article (PubMed ID: 29209797)
1. [Morphology of non cutaneous head and neck squamous cell carcinoma].
Weichert W; Ihrler S; Boxberg M; Agaimy A; Mollenhauer M; Hartmann A
Pathologe; 2018 Feb; 39(1):3-10. PubMed ID: 29209797
[TBL] [Abstract][Full Text] [Related]
2. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia.
Bhosale PG; Pandey M; Desai RS; Patil A; Kane S; Prabhash K; Mahimkar MB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):609-618.e7. PubMed ID: 27765330
[TBL] [Abstract][Full Text] [Related]
4. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
Wittekindt C; Wagner S; Mayer CS; Klußmann JP
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
[TBL] [Abstract][Full Text] [Related]
5. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
6. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
8. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
10. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist.
Westra WH
Semin Diagn Pathol; 2015 Jan; 32(1):42-53. PubMed ID: 25804343
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
Bhattacharjee A; Giri S; Roy M; Chakraborty A
J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus (HPV) infection leads to the development of head and neck lesions but offers better prognosis in malignant Indian patients.
Sarkar S; Alam N; Chakraborty J; Biswas J; Mandal SS; Roychoudhury S; Panda CK
Med Microbiol Immunol; 2017 Jun; 206(3):267-276. PubMed ID: 28343330
[TBL] [Abstract][Full Text] [Related]
13. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
15. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas.
Salazar C; Calvopiña D; Punyadeera C
Expert Rev Mol Diagn; 2014 Nov; 14(8):1033-40. PubMed ID: 25222489
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma.
Weiss D; Koopmann M; Rudack C
Head Neck; 2011 Jun; 33(6):856-62. PubMed ID: 20737490
[TBL] [Abstract][Full Text] [Related]
17. Impact of HPV infection on oral squamous cell carcinoma.
Götz C; Drecoll E; Straub M; Bissinger O; Wolff KD; Kolk A
Oncotarget; 2016 Nov; 7(47):76704-76712. PubMed ID: 27732948
[TBL] [Abstract][Full Text] [Related]
18. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.
Ma X; Sheng S; Wu J; Jiang Y; Gao X; Cen X; Wu J; Wang S; Tang Y; Tang Y; Liang X
Oncotarget; 2017 Jun; 8(26):42061-42075. PubMed ID: 28159935
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
20. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
